(PPHM:Consolidated Issue listed on NASDAQ Capital Market)
Mark R. Schleiss M.D.
Member of Scientific Resource Board of Anti Viral CMV, Peregrine Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 35 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Mark R. Schleiss, MD serves as Professor and Associate Head for Research and American Legion Chairman in the Department of Pediatrics and Director, Division of Infectious Diseases at University of Minnesota. Dr. Schleiss has been a Member of CMV Advisory Board of Alphavax, Inc. since January 30, 2008. Dr. Schleiss serves as a Member of Scientific Resource Board of Anti-Viral- CMV at Peregrine Pharmaceuticals Inc.
14282 Franklin AvenuePhone: 714-508-6000
Tustin, California 92780
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|J. Joseph Kim Ph.D.||Chief Executive Officer, President, Director and Member of Finance Committee|
Inovio Pharmaceuticals, Inc.
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Corporate Secretary and Director|
|Vijay B. Samant||Chief Executive Officer, President, Acting Chief Financial Officer and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|$515.0K||Compensation as of Fiscal Year 2014.|